XYLO TECHNOLOGIES LTD |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.71 USD | +4.27% |
|
+3.64% | -47.55% |
| Apr. 22 | Xylo Technologies Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Apr. 18 | Medigus Ltd. will Change its Ticker to XYLO from MDGS | CI |
Financials (USD)
| Sales 2022 | 91.86M | Sales 2023 | 91.72M | Capitalization | 5.66M |
|---|---|---|---|---|---|
| Net income 2022 | -9M | Net income 2023 | -16M | EV / Sales 2022 | -0.08 x |
| Net cash position 2022 | 14.92M | Net cash position 2023 | 2.75M | EV / Sales 2023 | 0.03 x |
| P/E ratio 2022 |
-0.77
x | P/E ratio 2023 |
-0.34
x | Employees | 84 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 87.23% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | +4.27% | ||
| 1 week | +3.64% | ||
| Current month | +6.88% | ||
| 1 month | -37.82% | ||
| 3 months | -45.37% | ||
| 6 months | -44.12% | ||
| Current year | -47.55% |
1 week
1.51
1.80
1 month
1.512.95
Current year
1.513.66
1 year
1.517.17
3 years
1.5136.75
5 years
1.5177.25
10 years
1.513 102.00
| Managers | Title | Age | Since |
|---|---|---|---|
Liron Carmel
CEO | Chief Executive Officer | 39 | 19-03-31 |
Tali Dinar
DFI | Director of Finance/CFO | 51 | 21-06-07 |
| Chief Tech/Sci/R&D Officer | 73 | 99-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Eliyahu Yoresh
CHM | Chairman | 54 | 18-08-31 |
Eli Cohen
BRD | Director/Board Member | 55 | 18-09-19 |
Ronen Rosenbloom
BRD | Director/Board Member | 52 | 18-09-19 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-02 | 1.71 | +4.27% | 12,874 |
| 24-05-01 | 1.64 | +2.49% | 2,583 |
| 24-04-30 | 1.6 | -4.19% | 14,701 |
| 24-04-29 | 1.67 | +1.83% | 16,318 |
| 24-04-26 | 1.64 | -0.61% | 12,066 |
Delayed Quote Nasdaq, May 02, 2024 at 04:30 pm EDT
More quotes
Xylo Technologies Ltd, formerly known ad Medigus Ltd, is an Israel-based medical device company specializing in developing minimally invasive endosurgical tools and imaging solutions across medical and industrial applications. The Company developed a range of micro video cameras under micro ScoutCam portfolio of products and the Medigus Ultrasonic Surgical Endostapler, or MUSE system endoscopic device for the treatment of gastroesophageal reflux disease (GERD).
Calendar
2024-09-01
- Q2 2024 Earnings Release (Projected)
Chiffre d''affaires - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -47.55% | 3.24M | |
| +7.62% | 218B | |
| +6.70% | 183B | |
| +11.94% | 134B | |
| +24.60% | 106B | |
| -2.66% | 61.12B | |
| +4.81% | 50.89B | |
| +11.55% | 51.26B | |
| -1.09% | 40.3B | |
| +26.82% | 32.05B |
- Stock Market
- Equities
- XYLO Stock
